Notice: This company has been marked as potentially delisted and may not be actively trading. INSU Acquisition Corp. II (INAQ) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsHeadlinesOwnershipShort InterestTrends INAQ vs. IQMD, GWII, THCP, SNTI, JYNT, APPS, REFR, VHC, XELB, and RMCOShould you be buying INSU Acquisition Corp. II stock or one of its competitors? The main competitors of INSU Acquisition Corp. II include Intelligent Medicine Acquisition (IQMD), Good Works II Acquisition (GWII), Thunder Bridge Capital Partners IV (THCP), Senti Biosciences (SNTI), Joint (JYNT), Digital Turbine (APPS), Research Frontiers (REFR), VirnetX (VHC), Xcel Brands (XELB), and Royalty Management (RMCO). INSU Acquisition Corp. II vs. Intelligent Medicine Acquisition Good Works II Acquisition Thunder Bridge Capital Partners IV Senti Biosciences Joint Digital Turbine Research Frontiers VirnetX Xcel Brands Royalty Management INSU Acquisition Corp. II (NASDAQ:INAQ) and Intelligent Medicine Acquisition (NASDAQ:IQMD) are both small-cap unclassified companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, media sentiment, profitability, valuation, institutional ownership, dividends, community ranking, risk and analyst recommendations. Does the MarketBeat Community believe in INAQ or IQMD? INSU Acquisition Corp. II and Intelligent Medicine Acquisition both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformINSU Acquisition Corp. IIN/AN/AIntelligent Medicine AcquisitionN/AN/A Do institutionals & insiders hold more shares of INAQ or IQMD? 15.9% of INSU Acquisition Corp. II shares are owned by institutional investors. Comparatively, 56.6% of Intelligent Medicine Acquisition shares are owned by institutional investors. 76.1% of INSU Acquisition Corp. II shares are owned by company insiders. Comparatively, 0.5% of Intelligent Medicine Acquisition shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Does the media prefer INAQ or IQMD? In the previous week, INSU Acquisition Corp. II had 2 more articles in the media than Intelligent Medicine Acquisition. MarketBeat recorded 2 mentions for INSU Acquisition Corp. II and 0 mentions for Intelligent Medicine Acquisition. INSU Acquisition Corp. II's average media sentiment score of 0.00 equaled Intelligent Medicine Acquisition'saverage media sentiment score. Company Overall Sentiment INSU Acquisition Corp. II Neutral Intelligent Medicine Acquisition Neutral Which has stronger earnings & valuation, INAQ or IQMD? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioINSU Acquisition Corp. IIN/AN/A-$650KN/AN/AIntelligent Medicine AcquisitionN/AN/AN/AN/AN/A Which has more risk and volatility, INAQ or IQMD? INSU Acquisition Corp. II has a beta of -0.02, indicating that its stock price is 102% less volatile than the S&P 500. Comparatively, Intelligent Medicine Acquisition has a beta of 0.03, indicating that its stock price is 97% less volatile than the S&P 500. Is INAQ or IQMD more profitable? Company Net Margins Return on Equity Return on Assets INSU Acquisition Corp. IIN/A N/A -33.22% Intelligent Medicine Acquisition N/A N/A N/A SummaryIntelligent Medicine Acquisition beats INSU Acquisition Corp. II on 3 of the 5 factors compared between the two stocks. Ad WealthPressThe Tesla Trade Is Back In BusinessIf you held shares of Tesla throughout 2024, you know It’s been a year of extreme highs and lows… But according to our one expert, new yearly highs are on the horizon… In his words, Tesla is building momentum like in 2020, especially as Trump supports the EV maker. Which is why we’re emailing you now… You see, most people will simply buy shares of Tesla ahead of the election… But as they say “There is more than one way to skin a cat” In fact, we’ve found another way to play shares of Tesla.Discover how to trade Tesla, simply follow this link here. Get INSU Acquisition Corp. II News Delivered to You Automatically Sign up to receive the latest news and ratings for INAQ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart INAQ vs. The Competition Export to ExcelMetricINSU Acquisition Corp. IIPatent owners & lessors IndustryUnclassified SectorNASDAQ ExchangeMarket Cap$71.72M$1.05B$106.71M$8.68BDividend YieldN/A6.83%5.19%4.05%P/E RatioN/A5.089.2315.11Price / SalesN/A199.121.1686.30Price / CashN/A12.2796.8936.41Price / Book-7.014.02519.875.88Net Income-$650,000.00-$7.75M$2.80M$225.31M INSU Acquisition Corp. II Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)INAQINSU Acquisition Corp. IIN/A$11.00-2.7%N/A+3.5%$71.72MN/A0.00N/ANews CoverageGap DownIQMDIntelligent Medicine AcquisitionN/A$11.04flatN/AN/A$64.75MN/A0.002,021GWIIGood Works II AcquisitionN/A$10.11flatN/AN/A$89.68MN/A0.002,021THCPThunder Bridge Capital Partners IVN/A$11.15flatN/A+9.1%$105.77MN/A0.002News CoveragePositive NewsSNTISenti Biosciences0.8355 of 5 stars$2.29-1.7%N/A-33.4%$10.49M$2.56M-0.184News CoveragePositive NewsGap UpJYNTJoint3.1323 of 5 stars$11.05-1.5%$17.50+58.4%+30.6%$165.53M$117.70M-9.69444Analyst UpgradeShort Interest ↓News CoverageAPPSDigital Turbine4.6398 of 5 stars$1.33-5.0%$2.38+78.6%-72.9%$137.96M$544.48M-0.45840Analyst DowngradeInsider BuyingShort Interest ↓Gap DownREFRResearch Frontiers0.0727 of 5 stars$1.98+0.5%N/A+97.0%$66.37M$910,000.00-66.006Gap UpVHCVirnetX0.1483 of 5 stars$5.85-0.8%N/A-22.6%$21.88M$10,000.00-1.1027XELBXcel Brands1.1933 of 5 stars$0.75-1.8%N/A-22.0%$17.69M$17.75M-0.8380Upcoming EarningsAnalyst ForecastRMCORoyalty Management1.4466 of 5 stars$1.04-4.6%N/A-77.6%$15.55M$360,000.000.00N/ANews CoveragePositive NewsGap Up Related Companies and Tools Related Companies Intelligent Medicine Acquisition Alternatives Good Works II Acquisition Alternatives Thunder Bridge Capital Partners IV Alternatives Senti Biosciences Alternatives Joint Alternatives Digital Turbine Alternatives Research Frontiers Alternatives VirnetX Alternatives Xcel Brands Alternatives Royalty Management Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:INAQ) was last updated on 11/15/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding INSU Acquisition Corp. II Please log in to your account or sign up in order to add this asset to your watchlist. Share INSU Acquisition Corp. II With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
